NCT03345173View on ClinicalTrials.gov

Facilitating Rapid Naltrexone Initiation

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 25, 2017

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Opioid Dependence
Interventions
DRUG

CI-581-a

Two infusions in the context of naltrexone induction protocol.

DRUG

CI-581-b

Two infusions in the context of naltrexone induction protocol.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER